Redox Regulation of Interleukin-4 Signaling

Immunity

Volumn 29, Issue 4, 2008, Pages 551-564

  Sharma, Pankaj ^a   Chakraborty, Rikhia ^a,b   Wang, Lu ^a   Min, Booki ^a   Tremblay, Michel L ^c   Kawahara, Tsukasa ^d   Lambeth, J David ^d   Haque, S Jaharul ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

MOLIMMUNO

Indexed keywords

CYTOKINE RECEPTOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; INSULIN RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 4 RECEPTOR; NOX5L PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE PHOSPHATASE 1B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; CELL LINE, TUMOR; CLONING, MOLECULAR; HUMANS; INTERLEUKIN-4; MICE; NADPH OXIDASE; OXIDATION-REDUCTION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; RECEPTOR, INSULIN; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION;

EID: 53349160071     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2008.07.019     Document Type: Article

References (57)

1. Banfi B., Molnar G., Maturana A., Steger K., Hegedus B., Demaurex N., and Krause K.H. A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 276 (2001) 37594-37601
2. Banfi B., Tirone F., Durussel I., Knisz J., Moskwa P., Molnar G.Z., Krause K.H., and Cox J.A. Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5). J. Biol. Chem. 279 (2004) 18583-18591
3. Buckley D.A., Cheng A., Kiely P.A., Tremblay M.L., and O'Connor R. Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts. Mol. Cell. Biol. 22 (2002) 1998-2010
4. Cheng G., Diebold B.A., Hughes Y., and Lambeth J.D. Nox1-dependent reactive oxygen generation is regulated by Rac1. J. Biol. Chem. 281 (2006) 17718-17726
5. Choi M.H., Lee I.K., Kim G.W., Kim B.U., Han Y.H., Yu D.Y., Park H.S., Kim K.Y., Lee J.S., Choi C., et al. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435 (2005) 347-353
6. Cool R.H., Merten E., Theiss C., and Acker H. Rac1, and not Rac2, is involved in the regulation of the intracellular hydrogen peroxide level in HepG2 cells. Biochem. J. 332 (1998) 5-8
7. Cross A.R., and Jones O.T. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem. J. 237 (1986) 111-116
8. DeSilva D.R., Jones E.A., Favata M.F., Jaffee B.D., Magolda R.L., Trzaskos J.M., and Scherle P.A. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J. Immunol. 160 (1998) 4175-4181
9. Duran A., Rodriguez A., Martin P., Serrano M., Flores J.M., Leitges M., Diaz-Meco M.T., and Moscat J. Crosstalk between PKCzeta and the IL4/Stat6 pathway during T-cell-mediated hepatitis. EMBO J. 23 (2004) 4595-4605
10. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., Normandin D., Cheng A., Himms-Hagen J., Chan C.C., et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283 (1999) 1544-1548
11. Fischer E.H., Charbonneau H., and Tonks N.K. Protein tyrosine phosphatases: A diverse family of intracellular and transmembrane enzymes. Science 253 (1991) 401-406
12. Flint A.J., Tiganis T., Barford D., and Tonks N.K. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 94 (1997) 1680-1685
13. Frey R.S., Gao X., Javaid K., Siddiqui S.S., Rahman A., and Malik A.B. Phosphatidylinositol 3-kinase gamma signaling through protein kinase Czeta induces NADPH oxidase-mediated oxidant generation and NF-kappaB activation in endothelial cells. J. Biol. Chem. 281 (2006) 16128-16138
14. Fu X., Beer D.G., Behar J., Wands J., Lambeth D., and Cao W. cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J. Biol. Chem. 281 (2006) 20368-20382
15. Fukuchi K., Watanabe H., Tomoyasu S., Ichimura S., Tatsumi K., and Gomi K. Phosphatidylinositol 3-kinase inhibitors, Wortmannin or LY294002, inhibited accumulation of p21 protein after gamma-irradiation by stabilization of the protein. Biochim. Biophys. Acta 1496 (2000) 207-220
16. Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H.J., and Johannes F.J. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 392 (1996) 77-80
17. Haque S.J., Harbor P., Tabrizi M., Yi T., and Williams B.R. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J. Biol. Chem. 273 (1998) 33893-33896
18. Haque S.J., Harbor P.C., and Williams B.R. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling. J. Biol. Chem. 275 (2000) 26500-26506
19. Haque S.J., and Sharma P. Interleukins and STAT signaling. Vitam. Horm. 74 (2006) 165-206
20. Haque S.J., Wu Q., Kammer W., Friedrich K., Smith J.M., Kerr I.M., Stark G.R., and Williams B.R. Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1. Proc. Natl. Acad. Sci. USA 94 (1997) 8563-8568
21. Harkins A.B., Kurebayashi N., and Baylor S.M. Resting myoplasmic free calcium in frog skeletal muscle fibers estimated with fluo-3. Biophys. J. 65 (1993) 865-881
22. Heldin C.H. Dimerization of cell surface receptors in signal transduction. Cell 80 (1995) 213-223
23. Ho J.L., Zhu B., He S., Du B., and Rothman R. Interleukin 4 receptor signaling in human monocytes and U937 cells involves the activation of a phosphatidylcholine-specific phospholipase C: A comparison with chemotactic peptide, FMLP, phospholipase D, and sphingomyelinase. J. Exp. Med. 180 (1994) 1457-1469
24. Ikizawa K., Kajiwara K., Koshio T., and Yanagihara Y. Possible role of tyrosine kinase activity in interleukin 4-induced expression of germ-line C epsilon transcripts in a human Burkitt lymphoma B-cell line, DND39. J. Allergy Clin. Immunol. 94 (1994) 620-624
25. Ikizawa K., and Yanagihara Y. Possible involvement of Shc in IL-4-induced germline epsilon transcription in a human B cell line. Biochem. Biophys. Res. Commun. 268 (2000) 54-59
26. Jagnandan D., Church J.E., Banfi B., Stuehr D.J., Marrero M.B., and Fulton D.J. Novel mechanism of activation of NADPH oxidase 5. calcium sensitization via phosphorylation. J. Biol. Chem. 282 (2007) 6494-6507
27. Jarvis W.D., Turner A.J., Povirk L.F., Traylor R.S., and Grant S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54 (1994) 1707-1714
28. Kawahara T., Ritsick D., Cheng G., and Lambeth J.D. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. J. Biol. Chem. 280 (2005) 31859-31869
29. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88 (1991) 4651-4655
30. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4 (2004) 181-189
31. Lambeth J.D., Kawahara T., and Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 43 (2007) 319-331
32. Lee S.R., Kwon K.S., Kim S.R., and Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273 (1998) 15366-15372
33. Mahadev K., Zilbering A., Zhu L., and Goldstein B.J. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J. Biol. Chem. 276 (2001) 21938-21942
34. Maiti N.R., Sharma P., Harbor P.C., and Haque S.J. Serine phosphorylation of Stat6 negatively controls its DNA-binding function. J. Interferon Cytokine Res. 25 (2005) 553-563
35. Meng T.C., Fukada T., and Tonks N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9 (2002) 387-399
36. Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., Leeder J.S., Freedman M., Cohen A., Gazit A., et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379 (1996) 645-648
37. Murata T., Hori M., Sakamoto K., Karaki H., and Ozaki H. Dexamethasone blocks hypoxia-induced endothelial dysfunction in organ-cultured pulmonary arteries. Am. J. Respir. Crit. Care Med. 170 (2004) 647-655
38. Myers M.P., Andersen J.N., Cheng A., Tremblay M.L., Horvath C.M., Parisien J.P., Salmeen A., Barford D., and Tonks N.K. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276 (2001) 47771-47774
39. Myers M.P., Stolarov J.P., Eng C., Li J., Wang S.I., Wigler M.H., Parsons R., and Tonks N.K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA 94 (1997) 9052-9057
40. Myhre O., Andersen J.M., Aarnes H., and Fonnum F. Evaluation of the probes 2′,7′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem. Pharmacol. 65 (2003) 1575-1582
41. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., and Paul W.E. The IL-4 receptor: Signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17 (1999) 701-738
42. O'Shea J.J., Gadina M., and Schreiber R.D. Cytokine signaling in 2002: New surprises in the Jak/Stat pathway. Cell 109 Suppl (2002) S121-S131
43. Ohara J., and Paul W.E. Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage. Nature 325 (1987) 537-540
44. Park H.S., Lee S.H., Park D., Lee J.S., Ryu S.H., Lee W.J., Rhee S.G., and Bae Y.S. Sequential activation of phosphatidylinositol 3-kinase, beta Pix, Rac1, and Nox1 in growth factor-induced production of H2O2. Mol. Cell. Biol. 24 (2004) 4384-4394
45. Persson C., Sjoblom T., Groen A., Kappert K., Engstrom U., Hellman U., Heldin C.H., den Hertog J., and Ostman A. Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 101 (2004) 1886-1891
46. Pfleger K.D., and Eidne K.A. Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). Nat. Methods 3 (2006) 165-174
47. Reid K., Guo T.Z., Davies M.F., and Maze M. Nifedipine, an L-type calcium channel blocker, restores the hypnotic response in rats made tolerant to the alpha-2 adrenergic agonist dexmedetomidine. J. Pharmacol. Exp. Ther. 283 (1997) 993-999
48. Rhee S.G., Bae Y.S., Lee S.R., and Kwon J. Hydrogen peroxide: A key messenger that modulates protein phosphorylation through cysteine oxidation. Sci. STKE 2000 (2000) PE1
49. Salmeen A., Andersen J.N., Myers M.P., Meng T.C., Hinks J.A., Tonks N.K., and Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423 (2003) 769-773
50. Seuwen K., and Boddeke H.G. Heparin-insensitive calcium release from intracellular stores triggered by the recombinant human parathyroid hormone receptor. Br. J. Pharmacol. 114 (1995) 1613-1620
51. Stam J.C., Michiels F., van der Kammen R.A., Moolenaar W.H., and Collard J.G. Invasion of T-lymphoma cells: Cooperation between Rho family GTPases and lysophospholipid receptor signaling. EMBO J. 17 (1998) 4066-4074
52. Tsien R.Y. New calcium indicators and buffers with high selectivity against magnesium and protons: Design, synthesis, and properties of prototype structures. Biochemistry 19 (1980) 2396-2404
53. van Montfort R.L., Congreve M., Tisi D., Carr R., and Jhoti H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423 (2003) 773-777
54. Wery-Zennaro S., Zugaza J.L., Letourneur M., Bertoglio J., and Pierre J. IL-4 regulation of IL-6 production involves Rac/Cdc42- and p38 MAPK-dependent pathways in keratinocytes. Oncogene 19 (2000) 1596-1604
55. Yamada T., Zhu D., Saxon A., and Zhang K. CD45 controls interleukin-4-mediated IgE class switch recombination in human B cells through its function as a Janus kinase phosphatase. J. Biol. Chem. 277 (2002) 28830-28835
56. Yuan Q., Gurish M.F., Friend D.S., Austen K.F., and Boyce J.A. Generation of a novel stem cell factor-dependent mast cell progenitor. J. Immunol. 161 (1998) 5143-5146
57. Zamorano J., Rivas M.D., Garcia-Trinidad A., Qu C.K., and Keegan A.D. Phosphatidylcholine-specific phospholipase C activity is necessary for the activation of STAT6. J. Immunol. 171 (2003) 4203-4209